8, 0%) efter 24 uger sammenlignet med et fald på 0, 02% hos patienter, der tik placebo som tillægsbehandling.
The addition of 100 mg sitagliptin to metformin reduced HbA1c levels by 0.67% (from around 8.0%) after 24 weeks, compared with a fall of 0.02% in the patients adding placebo.